Effect of trehalose on mortality and disease severity in ICU-admitted patients: Protocol for a triple-blind, randomized, placebo-controlled clinical trial
- PMID: 39021672
- PMCID: PMC11252791
- DOI: 10.1016/j.conctc.2024.101324
Effect of trehalose on mortality and disease severity in ICU-admitted patients: Protocol for a triple-blind, randomized, placebo-controlled clinical trial
Abstract
Background: Improvement in organ failure in intensive care unit (ICU) patients is accompanied by lower mortality rate. A disaccharide, trehalose is a candidate to improve organ failure and survival by autophagy induction and enhancing oxidative stress defense. The aim of this study is to assess the effectiveness of trehalose in improving clinical outcome and reducing mortality in ICU patients.
Methods: a triple-blind, randomized, placebo-controlled, two arm, parallel-group, superiority clinical trial will enroll 200 ICU-admitted patients at Imam Reza hospital, Mashhad, Iran. The patients will be randomly allocated to receive either a 100 ml solution of 15 % trehalose or normal saline intravenously. Primary outcomes include ICU mortality and 60-day mortality, while secondary outcomes focus on blood parameters on day 5 and length of hospital/ICU stay.
Conclusion: Trehalose has demonstrated beneficial effects in diverse patients; however, no study has evaluated its effect in all ICU-admitted patients. Consequently, this study provides an opportunity to investigate whether trehalose's anti-inflammatory effects, mediated by inducing autophagy and enhancing oxidative stress defense, can play a role in reducing mortality and improving clinical outcomes in the critically ill patients. If successful, trehalose could offer a potential therapeutic approach in the ICU setting.
Keywords: Clinical trial; Critical illness; Intensive care units; Mortality; Survival; Treatment outcome; Trehalose.
© 2024 The Author(s).
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
Effect of curcumin-pipeine supplementation on clinical status, mortality rate, oxidative stress, and inflammatory markers in critically ill ICU patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.Trials. 2021 Jul 6;22(1):434. doi: 10.1186/s13063-021-05372-9. Trials. 2021. PMID: 34229742 Free PMC article.
-
A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 admitted to the intensive care unit (MelCOVID study): a structured summary of a study protocol for a randomized controlled trial.Trials. 2020 Aug 5;21(1):699. doi: 10.1186/s13063-020-04632-4. Trials. 2020. PMID: 32758298 Free PMC article.
-
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9. Trials. 2020. PMID: 33115543 Free PMC article.
-
Chlorhexidine bathing of the critically ill for the prevention of hospital-acquired infection.Cochrane Database Syst Rev. 2019 Aug 30;8(8):CD012248. doi: 10.1002/14651858.CD012248.pub2. Cochrane Database Syst Rev. 2019. PMID: 31476022 Free PMC article.
-
REducing Deaths due to OXidative Stress (The REDOXS Study): Rationale and study design for a randomized trial of glutamine and antioxidant supplementation in critically-ill patients.Proc Nutr Soc. 2006 Aug;65(3):250-63. doi: 10.1079/pns2006505. Proc Nutr Soc. 2006. PMID: 16923310 Review.
References
-
- Vincent J.-L., Marshall J.C., Ñamendys-Silva S.A., François B., Martin-Loeches I., Lipman J., et al. Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit. Lancet Respir. Med. 2014;2(5):380–386. - PubMed
-
- Vincent J.-L., editor. Seminars in Respiratory and Critical Care Medicine. © Thieme Medical Publishers; 2011. Organ failure in the intensive care unit. - PubMed
LinkOut - more resources
Full Text Sources